Stanford University has created a new biosensor microchip that can speed up drug development with the help of more than 100,000 magnetically-sensitive nanosensors that can analyze how proteins bond, according to FierceBiotechResearch.

The sensors can simultaneously monitor thousands of times more proteins than existing technology--protein bonding is an essential part of the drug development process. The technology uses magnetic nanotags attached to the protein being studied.  For example, when developing a medication, the technology increases the sensitivity of the protein monitoring. It also has an analytical model that predicts the final outcome of an interaction after only a few minutes, in contrast to the hours it takes using current techniques.